MED240920P35000
- 14.50
- 0.000.00%
Medifast Newsroom
Medifast (MED): A Bull Case Theory
Personal Care Stocks Q2 Results: Benchmarking Medifast (NYSE:MED)
Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
Express News | Medifast Inc Shares Hit Session High in Late Afternoon, Last up 7.3% at $19.67
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
Medifast's (NYSE:MED) Soft Earnings Don't Show The Whole Picture
Express News | Medifast Inc : Stephens Cuts Target Price to $18 From $24
D.A. Davidson Maintains Medifast(MED.US) With Sell Rating, Cuts Target Price to $16.5
D.A. Davidson analyst Linda Bolton Weiser maintains $Medifast(MED.US)$ with a sell rating, and adjusts the target price from $17.5 to $16.5.According to TipRanks data, the analyst has a success rate
Analysts Offer Insights on Consumer Cyclical Companies: Penn National Gaming (PENN), Lincoln Edu (LINC) and Medifast (MED)
D.A. Davidson Sticks to Their Sell Rating for Medifast (MED)
Earnings Call: Medifast Eyes Growth With GLP-1 Products Amid Revenue Dip
Medifast (MED) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
Earnings Call Summary | Medifast(MED.US) Q2 2024 Earnings Conference
Express News | Medifast Inc : D.a. Davidson Cuts Target Price to $16.5 From $17.5
Medifast, Inc. (MED) Q2 2024 Earnings Call Transcript
Medifast | 10-Q: Q2 2024 Earnings Report
Medifast Non-GAAP EPS of $0.92 Beats by $0.53, Revenue of $168.6M Misses by $5.45M
Earnings Flash (MED) MEDIFAST Posts Q2 Revenue $168.6M, Vs. Street Est of $174.1M
Earnings Flash (MED) MEDIFAST Posts Q2 EPS $0.92, Vs. Street Est of $0.39